1514
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
THE IMPACT OF CORONAVIRUS INFECTION ON THE CLINICAL CONDITION,
LEVEL OF EXERCISE TOLERANCE, AND QUALITY OF LIFE IN PATIENTS WITH
CHRONIC HEART FAILURE
Majidov Sharifjon Xusenovich
Osiyo xalqaro universitetida Assistent
E-mail:
https://doi.org/10.5281/zenodo.14941473
Abstract.
Heart damage is a common complication of COVID-19. A study by Ruan Q.,
Xu Z., et al. in Wuhan found that heart disease, either alone or in combination with respiratory
failure, accounted for 40% of all deaths. On the other hand, pre-existing cardiovascular
disease (PCVD) increases the risk of complications, including death, in patients with COVID-
19. A meta-analysis by Li B. et al. of hospitalized patients with COVID-19 found that the
incidence of cardiovascular disease was 16.4% in patients not requiring intensive care, but
three times higher in patients requiring intensive care.
Keywords:
COVID-19, Ischemic heart disease, heart failure, exercise tolerance.
ВЛИЯНИЕ КОРОНАВИРУСНОЙ ИНФЕКЦИИ НА КЛИНИЧЕСКОЕ
СОСТОЯНИЕ, УРОВЕНЬ ПЕРЕНОСИМОСТИ ФИЗИЧЕСКИХ НАГРУЗОК И
КАЧЕСТВО ЖИЗНИ ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ
НЕДОСТАТОЧНОСТЬЮ
Аннотация.
Повреждение сердца является распространенным осложнением
COVID-19. Исследование, проведенное Ruan Q., Xu Z. и др. в Ухане, показало, что
сердечные заболевания, как в отдельности, так и в сочетании с дыхательной
недостаточностью, составляют 40% всех случаев смерти. С другой стороны, уже
имеющееся сердечно-сосудистое заболевание (PCVD) увеличивает риск осложнений,
включая смерть, у пациентов с COVID-19. Метаанализ госпитализированных
пациентов с COVID-19, проведенный Li B. и др., показал, что частота сердечно-
сосудистых заболеваний составила 16,4% у пациентов, не нуждающихся в интенсивной
терапии, но в три раза выше у пациентов, нуждающихся в интенсивной терапии.
Ключевые слова:
COVID-19,
ишемическая болезнь сердца, сердечная
недостаточность, переносимость физических нагрузок.
Research.
The clinical condition, exercise tolerance, and quality of life of patients in both groups
were studied, and the impact of coronavirus infection on these indicators was assessed. The
results of the clinical condition assessment scale - ХБСШ (ШОКС) in the group of patients
1515
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
with SYuY II FS who had COVID-19 were significantly different from the group of patients
with SYuY II FS who had not had COVID-19 (Tables 3.3.1 and 3.3.2). The average value of
the sum of ХБСШ (ШОКС) scores in patients with SYuY II FS who had COVID-19 was
33.3% higher than in patients without COVID-19, and was 4.5 ± 0.2 points and 6 ± 0.2 points
in the first and second groups, respectively. In patients with COVID-19 with stage III FS, the
average value of the sum of the SHOC scores was 20.8% higher than in patients without
COVID-19, and this indicator was 7.2 ± 0.2 points and 8.7 ± 0.1 points in the first and second
groups, respectively. Accordingly, the average value of the sum of the SHOC scores in patients
with stage II FS who had COVID-19 was 1.33 times higher than in patients without COVID-
19, and in patients with stage II FS who had COVID-19 was 1.2 times higher than in patients
without COVID-19.
Table 1.
Clinical status, exercise tolerance, and quality of life in patients with and without
COVID-19 with SYuY II FS
Indicators
COVID-19 not passed
(n=13)
COVID-19 spent
(n=14)
p
KHBSh – ШОКС
(score)
4,5 ± 0,2
6 ± 0,2***
<0,001
6 DYT (m)
363,9 ± 13,4
307,7 ± 7,9**
<0,01
Minnesot
questionnaire (score)
22,4 ± 2
33,7 ± 1,5***
<0,001
Note: *p – confidence level relative to the indicators of patients who did not have
COVID-19.
When examining the patients' exercise tolerance through the results of the 6-minute
walk test (6-MWT), it was found that coronavirus infection had a direct effect on this indicator
(Tables 3.3.1 and 3.3.2). In patients with stage II COVID-19, the average value of the sum of
the 6-MWT indicators was 18.3% lower than in patients without COVID-19, and was 363.9 ±
13.4 meters and 307.7 ± 7.9 meters in the first and second groups, respectively. In patients with
stage III COVID-19, the average value of the sum of the 6-MWT indicators was 34.3% lower
than in patients without COVID-19, and was 255.8 ± 7.2 meters and 190.5 ± 6.1 meters in the
first and second groups, respectively. Accordingly, the average value of the sum of 6 DYT
indicators was 1.18 times lower in COVID-19 patients with SYuY II FS than in patients who
did not have COVID-19, and 1.34 times lower in COVID-19 patients with SYuY III FS than in
patients who did not have COVID-19.
Table-2
1516
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
Clinical status, exercise tolerance, and quality of life in patients with and without
COVID-19 with stage III FS
Indicators
COVID-19 not
passed (n=17)
COVID-19 spent
(n=16)
p
KHBSh – ШОКС
(ball)
7,2 ± 0,2
8,7 ± 0,1***
<0,001
6 DYT (m)
255,8 ± 7,2
190,5 ± 6,1***
<0,001
Minnesot
questionnaire (score)
36,4 ± 2
54,6 ± 2,4***
<0,001
Note: *p – confidence level relative to the indicators of patients who did not have
COVID-19.
Also, according to the results of the Minnesota questionnaire, there was a difference in
the overall index of quality of life of patients (Tables 1 and 2). According to the presented data,
in patients with SYuY II FS who had COVID-19, the average value of the sum of the
Minnesota questionnaire scores was 50.4% higher than in patients without COVID-19, and was
22.4 ± 2 points and 33.7 ± 1.5 points in the first and second groups, respectively. In patients
with SYuY III FS who had COVID-19, the average value of the sum of the Minnesota
questionnaire scores was 50% higher than in patients without COVID-19, and was 36.4 ± 2
points and 54.6 ± 2.4 points in the first and second groups, respectively. Accordingly, the mean
value of the Minnesota questionnaire score was 1.5 times higher in COVID-19 patients with
SYuY II FS than in patients without COVID-19, and 1.5 times higher in COVID-19 patients
with SYuY III FS than in patients without COVID-19. Thus, infection with coronavirus
infection in patients with SYuY complications negatively affects their clinical condition, level
of tolerance to physical exertion, and quality of life.COVID-19 o‘tkazmagan bemorlar klinik
holati, jismoniy yuklamaga nisbatan tolerantlik darajasi va hayot sifati ko‘rsatkichlarining qon
zarobidagi NT-proBNP miqdori bilan o‘zaro korrelyatsion bog‘liqligini tekshirish natijasida
quyidagilar aniqlandi: bemorlar klinik holati ko‘rsatkichlari (ШОКС) va NT-proBNP o‘rtasida
II FS ga ega bemorlarda kuchsiz to‘g‘ri bog‘lanish (r= 0,08), III FS ga ega bemorlarda kuchsiz
to‘g‘ri bog‘lanish (r=0,14); jismoniy yuklamaga tollerantlik darajasi va NT-proBNP o‘rtasida II
FS ga ega bemorlarda kuchsiz to‘g‘ri bog‘lanish (r=-0,06), III FS ga ega bemorlarda kuchsiz
teskari bog‘lanish (r=-0,23); hayot sifati ko‘rsatkichlari va NT-proBNP o‘rtasida II FS ga ega
bemorlarda kuchsiz to‘g‘ri bog‘lanish (r=0,16), III FS ga ega bemorlarda o‘rtacha kuchdagi
to‘g‘ri bog‘lanish (r= 0,47) mavjud.
1517
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
Conclusion.
As can be seen from the above, coronavirus infection can cause various
complications in the div for a long time after recovery from the disease. In post-COVID
patients, significant negative changes were detected in serum NT-proBNP levels, cardiac
ExoKG parameters, clinical condition, exercise tolerance level, and quality of life indicators. It
was also proven that these changes increase depending on the severity of the disease.
REFERENCES
1.
Saodat, A., Vohid, A., Ravshan, N., & Shamshod, A. (2020). MRI study in patients with
idiopathic cokearthrosis of the hip joint.
International Journal of Psychosocial
Rehabilitation
,
24
(2), 410-415.
2.
Axmedov, S. J. (2023). EFFECTS OF THE DRUG MILDRONATE.
Innovative
Development in Educational Activities
,
2
(20), 40-59.
3.
Jamshidovich, A. S. (2023). ASCORBIC ACID: ITS ROLE IN IMMUNE SYSTEM,
CHRONIC
INFLAMMATION
DISEASES
AND
ON
THE
ANTIOXIDANT
EFFECTS.
EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE
,
3
(11),
57-60.
4.
Jamshidovich, A. S. (2023). THE ROLE OF THIOTRIAZOLINE IN THE
ORGANISM.
Ta'lim innovatsiyasi va integratsiyasi
,
9
(5), 152-155.
5.
Jamshidovich,
A.
S.
(2023).
HEPTRAL
IS
USED
IN
LIVER
DISEASES.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
35
(3),
76-78.
6.
Jamshidovich, A. S. (2023). EFFECT OF TIVORTIN ON CARDIOMYOCYTE CELLS
AND ITS ROLE IN MYOCARDIAL INFARCTION.
Gospodarka i Innowacje.
,
42
, 255-
257.
7.
Jamshidovich,
A.
S.
(2024).
NEUROPROTECTIVE
EFFECT
OF
CITICOLINE.
EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE
,
4
(1),
1-4.
8.
Jamshidovich, A. S. (2024). THE ROLE OF TRIMETAZIDINE IN ISCHEMIC
CARDIOMYOPATHY.
Journal of new century innovations
,
44
(2), 3-8.
9.
Jamshidovich,
A.
S.
(2024).
ВСЕ
ЭФФЕКТЫ
ПРЕПАРАТА
ИМУДОН.
TADQIQOTLAR
,
31
(2), 39-43.
10.
Jamshidovich, A. S. (2024). SPECIFIC FEATURES OF THE EFFECT OF THE
HEPARIN DRUG.
TADQIQOTLAR
,
31
(2), 34-38.
11.
Jamshidovich, A. S. (2024). USE OF GLUCOCORTICOSTEROIDS IN PEDIATRIC
PRACTICE.
TADQIQOTLAR
,
31
(2), 29-33.
1518
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
12.
Jamshidovich,
A.
S.
(2024).
РОЛЬ
ИНТЕЛЛАНОВОГО
СИРОПА
И
ЦИАНОКОБАЛАМИНА В УЛУЧШЕНИИ ПАМЯТИ.
TADQIQOTLAR
,
31
(2), 44-48.
13.
Jamshidovich, A. S. (2024). TREATMENT OF POLYNEUROPATHY WITH
BERLITHION.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 201-209.
14.
Jamshidovich, A. S. (2024). USE OF ASCORIL IN BRONCHIAL ASTHMA.
Ta'limning
zamonaviy transformatsiyasi
,
4
(1), 191-200.
15.
Jamshidovich,
A.
S.
(2024).
THE
IMPORTANCE
OF
THE
DRUG
ARTOXAN.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 182-190.
16.
Jamshidovich, A. S. (2024). THE ROLE OF RENGALIN IN CHRONIC
BRONCHITIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 116-123.
17.
Jamshidovich, A. S. (2024). THE ROLE OF ALMAGEL DRUG IN GASTRIC AND
DUODENAL WOUND DISEASE.
Ta'limning zamonaviy transformatsiyasi
,
4
(1), 173-
181.
18.
Jamshidovich, A. S. (2024). THE ROLE OF CODELAK BRONCHO SYRUP IN
CHILDREN'S PRACTICE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 109-115.
19.
Jamshidovich, A. S. (2024). THE AEVIT DRUG EFFECT.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(4), 124-132.
20.
Jamshidovich, A. S. (2024). THE IMPORTANCE OF ALCHEBA DRUG IN POST-
STROKE APHASIA.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 132-138.
21.
Jamshidovich, A. S. (2024). THE ROLE OF HYALURON CHONDRO DRUG IN
OSTEOARTHROSIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(4), 139-145.
22.
Jamshidovich,
A.
S.
(2024).
EFFECT
OF
SIMETHICONE
DROP
IN
FLATULENCE.
Лучшие интеллектуальные исследования
,
14
(1), 95-101.
23.
Jamshidovich, A. S. (2024). BENEFITS OF BETADINE SOLUTION.
Лучшие
интеллектуальные исследования
,
14
(1), 116-122.
24.
Jamshidovich, A. S. (2024). EFFECT INHALED GLUCOCORTICOIDS IN CHRONIC
OBSTRUCTIVE
PULMONARY
DISEASE
AND
BRONCHIAL
ASTHMA.
TADQIQOTLAR
,
31
(1), 171-180.
25.
Jamshidovich, A. S. (2024). USE OF VIGANTOL IN RICKETS.
Лучшие
интеллектуальные исследования
,
14
(1), 102-108.
1519
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
26.
Jamshidovich, A. S. (2024). THE VITAPROST DRUG RESULTS.
Лучшие
интеллектуальные исследования
,
14
(1), 109-115.
27.
Jamshidovich, A. S. (2024). THE ROLE OF BISEPTOL DRUG IN URINARY TRACT
DISEASE.
Лучшие интеллектуальные исследования
,
14
(1), 89-94.
28.
Jamshidovich,
A.
S.
(2024).
PROPERTIES
OF
THE
DRUG
DORMIKIND.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(5), 88-92.
29.
Jamshidovich, A. S., & Komilovich, E. B. (2024). IMMUNOMODULATORY
FUNCTION OF DIBAZOL DRUG.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ
ИДЕИ В МИРЕ
,
38
(5), 83-87.
30.
Jamshidovich, A. S., & Komilovich, E. B. (2024). ADVANTAGES OF THE DRUG
HEPTRAL.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(5),
98-101.
31.
Эргашов, Б. К., & Ахмедов, Ш. Ж. (2024). ГИПЕРТОНИЧЕСКАЯ БОЛЕЗНЬ
ЭТИОЛОГИЯ.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 59-69.
32.
Komilovich, E. B., & Jamshidovich, A. S. (2024). HYPERTENSION, CLASSIFICATION
AND PATHOGENESIS.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 50-58.
33.
Komilovich, E. B., & Jamshidovich, A. S. (2024). YURAK ISHEMIYASI.
STENOKARDIYADA SHOSHILINCH TIBBIY YORDAM.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 12-20.
34.
Komilovich,
E.
B.,
&
Jamshidovich,
A.
S.
(2024).
HYPERTENSION
ETIOLOGY.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6),
32-41.
35.
Komilovich, E. B., & Jamshidovich, A. S. (2024). CARDIAC ISCHEMIA. ANGINA
NURSING DIAGNOSIS AND CARE.
Journal of new century innovations
,
46
(1), 44-52.
36.
Jamshidovich, A. S. (2024). IMPORTANT INDICATIONS OF THE DRUG
WOBENZYM.
Journal of new century innovations
,
46
(1), 29-32.
37.
Jamshidovich, A. S. (2024). THE RESULTS OF THE EFFECT OF THE DRUG
VALIDOL.
Journal of new century innovations
,
46
(1), 19-23.
38.
Jamshidovich, A. S. (2024). VIFERON USE IN CHILDREN.
Journal of new century
innovations
,
46
(1), 24-28.
1520
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
39.
Jamshidovich,
A.
S.
(2024).
USE
OF
DUSPATALIN
(MEBEVERINE
HYDROCHLORIDE) IN GASTROINTESTINAL DISEASES.
ОБРАЗОВАНИЕ НАУКА
И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(5), 93-97.
40.
Jamshidovich, A. S. (2024). ЭФФЕКТЫ СИРОПА ДЕПАКИНА (ВАЛЬПРОЕВАЯ
КИСЛОТА).
Ta'lim innovatsiyasi va integratsiyasi
,
14
(2), 148-152.
41.
Jamshidovich, A. S., & Komilovich, E. B. (2024). THE IMPORTANCE OF THE DRUG
ALLOCHOL
FOR
CHRONIC
CHOLECYSTITIS.
Ta'lim
innovatsiyasi
va
integratsiyasi
,
14
(2), 133-137.
42.
Jamshidovich, A. S., & Komilovich, E. B. (2024). ВАЖНЫЕ СВОЙСТВА
ПРЕПАРАТА
ДЕ-НОЛ
(субцитрат
висмута).
Ta'lim
innovatsiyasi
va
integratsiyasi
,
14
(2), 143-147.
43.
Jamshidovich, A. S., & Komilovich, E. B. (2024). SPECIAL FEATURES OF
BUDECTON DRUG.
Ta'lim innovatsiyasi va integratsiyasi
,
14
(2), 138-142.
44.
Jamshidovich, A. S. (2024). ЭФФЕКТИВНОЕ ВОЗДЕЙСТВИЕ ПРЕПАРАТА
КЕЙВЕР.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 137-143.
45.
Jamshidovich, A. S. (2024). USEFUL PROPERTIES OF THE DRUG YODOFOL.
Ta'lim
innovatsiyasi va integratsiyasi
,
15
(3), 144-149.
46.
Jamshidovich, A. S. (2024). FITOTERAPIYANING AKUSHER-GINEKOLOGIYADA
AHAMIYATI.
Лучшие интеллектуальные исследования
,
15
(2), 121-125.
47.
Jamshidovich, A. S. (2024). THE IMPORTANCE OF THE DRUG DOPROKIN.
Лучшие
интеллектуальные исследования
,
15
(2), 109-114.
48.
Jamshidovich, A. S. (2024). THE EFFECT OF DOSTINEX ON THE BODY.
Лучшие
интеллектуальные исследования
,
15
(2), 115-120.
49.
Jamshidovich, A. S. (2024). РЕЗУЛЬТАТЫ ЭФФЕКТИВНОГО ДЕЙСТВИЯ
ПРЕПАРАТА КАНЕФРОН.
Лучшие интеллектуальные исследования
,
15
(2), 138-143.
50.
Jamshidovich,
A.
S.
(2024). СОВРЕМЕННЫЕ ЭФФЕКТЫ ПРЕПАРАТА
ИНДОЛ.
Лучшие интеллектуальные исследования
,
15
(2), 126-131.
51.
Jamshidovich, A. S. (2024). EFFECT OF ISMIZHEN DRUG ON BODY
IMMUNITY.
Лучшие интеллектуальные исследования
,
15
(2), 132-137.
52.
Jamshidovich, A. S. (2024). POSITIVE EFFECTS OF THE DRUG CARCIL.
Ta'lim
innovatsiyasi va integratsiyasi
,
15
(3), 127-131.
53.
Jamshidovich, A. S. (2024). PЕЗУЛЬТАТЫ ЭФФЕКТИВНОГО ДЕЙСТВИЯ
KАВИНТОНА.
Ta'lim innovatsiyasi va integratsiyasi
,
15
(3), 132-136.
54.
Jamshidovich, A. S. (2024). Современный Эффект Спрея Мометазон.
Research
Journal of Trauma and Disability Studies
,
3
(3), 62-65.
1521
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
55.
Jamshidovich, A. S. (2024). THE ROLE OF" SIMONTE PLUS" DRUG IN THE
MODERN TREATMENT OF BRONCHIAL ASTHMA.
EUROPEAN JOURNAL OF
MODERN MEDICINE AND PRACTICE
,
4
(5), 66-70.
56.
Jamshidovich, A. S. (2024). FEATURES OF THE BIOMECHANISM OF THE DRUG
LEVOMYCETIN (CHLORAMPHENICOL).
EUROPEAN JOURNAL OF MODERN
MEDICINE AND PRACTICE
,
4
(9), 298-301.
57.
Jamshidovich, A. S. (2024). THE MOST IMPORTANT INDICATORS OF OMEGA 3
SUBSTANCE IN THE METABOLISM OF THE HUMAN BODY.
EUROPEAN
JOURNAL OF MODERN MEDICINE AND PRACTICE
,
4
(10), 113-117.
58.
Komilovich, E. B., & Khalimovich, M. N. (2024). CARDIAC ISCHEMIA. ANGINA
CLINICAL FORMS AND DIAGNOSIS.
Journal of new century innovations
,
46
(1), 70-
78.
59.
Komilovich, E. B. (2024). CORONARY HEART DISEASE. ANGINA EMERGENCY
CARE.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(7), 235-
242.
60.
Komilovich, E. B. (2024). YURAK ISHEMIK KASALLIGI. STENOKARDIYANI
DAVOLASHNING ZAMONAVIY TAMOYILLARI.
ОБРАЗОВАНИЕ НАУКА И
ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 3-11.
61.
Jamshidovich, A. S. (2024). THE MOST IMPORTANT BENEFITS OF GINGER FOR
THE HUMAN BODY'S IMMUNITY.
EUROPEAN JOURNAL OF MODERN MEDICINE
AND PRACTICE
,
4
(11), 269-273.
62.
Axmedov, S. (2024). THE SPECIFIC EFFECT OF THE DRUG" BAKLASAN" IN
CEREBROVASCULAR
DISEASES
AND
ITS
PRACTICAL
SIGNIFICANCE
TODAY.
Modern Science and Research
,
3
(12), 485-492.
63.
Komilovich, E. B. Z. (2023). Coronary Artery Disease.
EUROPEAN JOURNAL OF
MODERN MEDICINE AND PRACTICE
,
3
(12), 81-87.
64.
Komilovich,
E.
B.
(2024).
CORONARY
HEART
DISEASE.
ANGINA
TREATMENT.
Journal of new century innovations
,
46
(1), 95-104.
65.
Komilovich, E. B. (2024). HYPERTENSION TREATMENT.
ОБРАЗОВАНИЕ НАУКА
И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(7), 227-234.
66.
Эргашов, Б. К. (2024). ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА. СТЕНОКАРДИЯ
ПРОФИЛАКТИКА.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 21-31.
67.
Axmedov, S. (2025). ВАЖНЫЕ СВОЙСТВА ПРЕПАРАТА ЭСКУЗАН ПРИ
СОСУДИСТЫХ ЗАБОЛЕВАНИЯХ.
Modern Science and Research
,
4
(1), 380-387.
1522
ResearchBib IF - 11.01, ISSN: 3030-3753, Volume 2 Issue 2
68.
Эргашов,
Б.
К.
(2024).
ГИПЕРТОНИЧЕСКАЯ
БОЛЕЗНЬ
ДИАГНОСТИКА.
ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В
МИРЕ
,
38
(6), 70-78.
69.
Komilovich, E. B. (2024). HYPERTENSION DIAGNOSTICS.
ОБРАЗОВАНИЕ НАУКА
И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ
,
38
(6), 42-49.
70.
Xusenovich, M. S., & Turаpjаnovnа, Z. M. (2024). SEMIZLIKNING TURLI
FENOTIPLARDA KARDIOMETABOLIK XAVF OMILLARINI TAQQOSLASH.
SO
‘NGI ILMIY TADQIQOTLAR NAZARIYASI
,
7
(4), 112-116.
71.
Husenovich, M. S., & Turabdjanovna, Z. M. (2024). STUDY OF DIURNAL PROFILE
OF
ARTERIAL
HYPERTENSION
IN
DIFFERENT
PHENOTYPE
OBESITY.
образование наука и инновационные идеи в мире
,
43
(1), 129-131.
72.
Xusenovich, M. S. (2024, September). SEMIZLIKNI TURLI FENOTIPLARIDA
YURAK QON-TOMIR KASALLIKLARINI KELIB CHIQISH XAVFI PROGNOZI.
In
INTERNATIONAL SCIENTIFIC RESEARCH CONFERENCE
(Vol. 3, No. 26, pp. 15-
18).
73.
Xusenovich, M. S. (2024). O ‘ZBEKISTONDA RESPUBLIKASIDA YURAK-QON
TOMIR KASALLIKLARI TARQALISHI VA HOZIRGI KUNDAGI KO’RILAYOTGAN
CHORA TADBIRLAR.
AMERICAN JOURNAL OF SOCIAL SCIENCE
,
2
(3), 79-82.
74.
Xusenovich, M. S., & Allayarovich, A. A. (2024). O ‘ZBEKISTONDA YURAK-QON
TOMIR
KASALLIKLARI
TARQALISHI
VA
HOZIRGI
KUNDAGI
TENDENSIYASI.
MODELS AND METHODS FOR INCREASING THE EFFICIENCY
OF INNOVATIVE RESEARCH
,
4
(38), 54-57.
75.
Ravshanovna, X. L. (2021, June). MINIMALLY INVASIVE METHODS OF
TREATMENT OF DENTAL CARIES IN ADULTS. In
" ONLINE-CONFERENCES"
PLATFORM
(pp. 118-119).
